Hot Topic QuickTakes VL

SPARTAN: A Study of Apalutamide in Men with M0 Castration-Resistant Prostate Cancer M0 CRPC) - Alan Bryce

Details
(Length of Presentation and Discussion: 9 minutes) Alan Bryce provides an overview of results from SPARTAN: A Study of Apalutamide (ARN-509) in Men with Non-Metastatic Castration-resistant Prostate Cancer - and the subsequent FDA approval of apalutamide for treatment of men with M0 castration resistant prostate cancer ( M0 CRPC). The presentation includes a review of the data on the primary and se...

Radical Prostatectomy for Patients with Oligometastatic Prostate Cancer - Robert Hamilton

Details
(Length of Discussion: 18 min) Dr. Robert Hamilton, a Staff Urologic Oncologist from Princess Margaret Cancer Centre in Toronto, Canada discusses radical prostatectomy for patients with oligometastatic prostate cancer. He overviews the clinical and biological rationale for radical prostatectomy in the oligometastases setting and highlights the role of novel imaging. He reviews four major PET trace...

DNA Next Generation Sequence in the Prevention of Infectious Complications After Transrectal Prostate Biopsy - Vladimir Mouraviev

Details
(Length of discussion ~ 6 minutes) E. David Crawford hosts a discussion with Vladimir Mouraviev on a trial regarding infection and sepsis following transrectal ultrasound-guided prostate biopsies and the use of next-generation sequencing to identify multiple organisms that pose an infection risk following these biopsies. A key finding of the trial was that based on these results, the targeted prop...

Prostate Cancer: Assorted Mortality Statistics - John Davis

Details
(Length of discussion - 6 minutes) Prostate Cancer: Assorted Mortality Statistics - John Davis E. David Crawford of the University of Colorado hosts a discussion with John Davis from MD Anderson Cancer Center on prostate cancer mortality rate in which the U.S. Services Preventive Task Force (USPSTF) claimed was 1 in 200 following radical prostatectomy (RP). Dr. Davis took a closer look at these st...

Discussion on CHAARTED, LATITUDE and STAMPEDE Trials

Details
(Length of lecture ~ 28 minutes) E. David Crawford hosts a discussion with three physicians who recently reported their findings from ASCO 2017 meeting on the CHAARTED, LATITUDE and STAMPEDE clinical trials, which will have a major impact on the treatment and survival benefits for men with prostate cancer. Elizabeth Kessler discusses the use of chemotherapy (docetaxel) in hormone sensitive metasta...

Over-treatment of Renal Tumors: The Turtle in the Room - Robert G. Uzzo

Details
(Length of discussion - 11 minutes) Kidney cancer, like all cancers, has a spectrum of risk. There are groups of patients with incidentally detected asymptomatic, small renal masses that act relatively indolent and are often over-diagnosed and over-treated in some patients. The issue is defining who they are when they should or should not be treated. Related Content: Watch: Adjuvant Therapies for...

Adjuvant Therapies for Renal Cell Carcinoma - Robert Uzzo

Details
(Length of discussion - 21 minutes) David Crawford discusses adjuvant therapy in kidney cancer with Robert Uzzo, and the fact that although there have been three decades of trials, there is still no approved therapies to treat the disease. However, Dr. Uzzo points to the S-TRAC trial as a step forward in that research space. Related Content: Watch: Over-treatment of Renal Tumors: The Turtle in the...

Immunotherapy in Bladder Cancer - Alan Bryce

Details
Immunotherapy in Bladder Cancer Biographies: E. David Crawford Alan Bryce, MD is the Medical Director of the Genomic Oncology Clinic at Mayo Clinic Arizona where he utilizes whole genome sequencing of tumors to identify key driver mutations. His clinical practice centers on genitourinary malignancies (prostate, kidney, bladder, and testicular cancers) and melanoma. Dr. Bryce participates in commun...

Preliminary Data from the PROCEED Registry- Oliver Sartor

Details
Overall Survival Analysis of African Americans and Caucasian Patients Receiving Sipuleucel-T: Preliminary Data from the PROCEED Registry Read the Abstract Biographies: E. David Crawford Oliver Sartor is the only medical oncologist in Louisiana specializing in the treatment of prostate cancer patients. Dr. Sartor, the Laborde Professor of Cancer Research in the Medicine and Urology Departments of T...

Genetics in Prostate Cancer - Alan Bryce

Details
Genetics in Prostate Cancer - Germline BRCA mutations Biographies: E. David Crawford Alan Bryce, MD
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe